Claims
- 1. A method of treating individuals suffering from xeroderma pigmentosum which comprises administering topically to the affected area of an individual in need of such therapy an effective amount of a glucocorticoid carboxylic acid ester sufficient to prevent skin cancer after exposure to UV radiation.
- 2. The method according to claim 1 wherein the glucocorticoid carboxylic acid ester is triamcinolone acetonide 21-oic acid methyl ester.
RELATED APPLICATIONS
The present Application is a Continuation-In-Part of co-pending application Ser. No. 053,379, filed May 22, 1987, which is in turn a Continuation-In-Part of application Ser. No. 030,764, filed Mar. 25, 1987, by the inventors herein, and applicants claim the benefits of 35 U.S.C. .sctn.120 therefrom.
US Referenced Citations (5)
Non-Patent Literature Citations (5)
Entry |
Laurent et al, Chem. Abs., 1975, vol. 83, 164419h. |
Laurent et al (I), Chem. Abst., 1974, vol. 81, p. 105817x. |
Gorsline et al, Chem. Abst., 1985, vol. 102, 125, 758j. |
Lowe, N. J., J. Invest. Dermatol., 77, 147-153 (1981). |
Lowe, N. J., et al., Cancer Research, 42, 3941-3943 (1982). |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
53379 |
May 1987 |
|
Parent |
30764 |
Mar 1987 |
|